Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFRSF8/CD30 Antibody (Brentuximab vedotin)

Catalog No.
F1042
Anti-TNFRSF8/CD30 Antibody (Brentuximab vedotin)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Brentuximab vedotin solution is a solution form of Brentuximab vedotin. Brentuximab vedotin (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) containing an anti-CD30 antibody and the cytotoxic agent monomethyl auristatin E (MMAE).

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.48 kDa

Shipping

Dry ice

Cas No.

914088-09-8

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Adcetris, SGN-35, cAC10-vcMMAE

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P28908

Reactivity

Human

Conjugation

MMAE

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

MMAE is conjugated by sulfhydryl coupling,the DAR value of Anti-TNFRSF8/CD30 Antibody (Brentuximab vedotin) antibody is 4.0.

Target

TNFRSF8 / CD30

Note

Please avoid freeze-thaw cycles.